Cas:41088-85-1 N-[(Benzyloxy)carbonyl]-D-homoserine manufacturer & supplier

We serve Chemical Name:N-[(Benzyloxy)carbonyl]-D-homoserine CAS:41088-85-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-[(Benzyloxy)carbonyl]-D-homoserine

Chemical Name:N-[(Benzyloxy)carbonyl]-D-homoserine
CAS.NO:41088-85-1
Synonyms:(2R)-4-hydroxy-2-(phenylmethoxycarbonylamino)butanoic acid;N-[(Benzyloxy)carbonyl]-D-homoserine;D-Homoserine, N-[(phenylmethoxy)carbonyl]-
Molecular Formula:C12H15NO5
Molecular Weight:253.251
HS Code:2924299090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:519.9±50.0 °C at 760 mmHg
Density:1.3±0.1 g/cm3
Index of Refraction:1.564
PSA:99.35000
Exact Mass:253.095016
LogP:1.30

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (2R)-4-hydroxy-2-(phenylmethoxycarbonylamino)butanoic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,D-Homoserine, N-[(phenylmethoxy)carbonyl]- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-Homoserine, N-[(phenylmethoxy)carbonyl]- Use and application,N-[(Benzyloxy)carbonyl]-D-homoserine technical grade,usp/ep/jp grade.


Related News: However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. N-[(Benzyloxy)carbonyl]-D-homoserine manufacturer However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. N-[(Benzyloxy)carbonyl]-D-homoserine supplier The Company��s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line. N-[(Benzyloxy)carbonyl]-D-homoserine vendor However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. N-[(Benzyloxy)carbonyl]-D-homoserine factory In terms of business, the industrial business increased by 7.97% year-on-year, while the revenue from the trading business shrank to a certain extent. The growth rate of industrial business was significantly slower than 24% in the first half of the year, showing that the growth rate of industrial business was lower in the third quarter, which was also the main reason for the decline in the company’s operating income in the third quarter. The company’s industrial business is mainly pesticide intermediates, accounting for about 85%. The scale of the pesticide intermediate business is large and the base is high, which is putting pressure on growth.